Rockefeller Capital Management
PRAX icon

Rockefeller Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Rockefeller Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$94.4K Buy
324
+9
+3% +$2.98K ﹤0.01% 3105
2026
Q2 		$105K Hold
315
– – ﹤0.01% 2960
2026
Q1 		$101K Buy
315
+251
+392% +$77.6K ﹤0.01% 2864
2025
Q4 		$18.9K Buy
64
+62
+3,100% +$11.5K ﹤0.01% 3536
2025
Q3 		$106 Buy
+2
New +$97 ﹤0.01% 4374
2023
Q1 		– Sell
-4
Closed – – 3403
2022
Q4 		$0 Sell
4
-29
-88% -$904 ﹤0.01% 4138
2022
Q3 		$1K Sell
33
-11
-25% -$548 ﹤0.01% 3772
2022
Q2 		$1K Buy
44
+13
+42% +$1.39K ﹤0.01% 3996
2022
Q1 		$4K Buy
31
+3
+11% +$616 ﹤0.01% 3436
2021
Q4 		$8K Buy
28
+1
+4% +$293 ﹤0.01% 3093
2021
Q3 		$7K Hold
27
– – ﹤0.01% 3054
2021
Q2 		$7K Buy
+27
New +$9.7K ﹤0.01% 2931

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Rockefeller Capital Management's PRAX Position: Q3 2026 in Review

Rockefeller Capital Management increased its Praxis Precision Medicines (PRAX) stake by 2.9% in Q3 2026, buying an estimated $2.98K and bringing the position to 324 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

Rockefeller Capital Management first reported a position in PRAX in Q2 2021 and has held it in 12 quarters since. The position peaked at $105K in Q2 2026. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Rockefeller Capital Management held 324 shares of Praxis Precision Medicines worth $94.4K as of Q3 2026.
  • Rockefeller Capital Management bought 9 Praxis Precision Medicines shares in Q3 2026, an estimated $2.98K.
  • Praxis Precision Medicines made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3105 holding.
  • Rockefeller Capital Management first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 12 quarters since.
  • Rockefeller Capital Management's Praxis Precision Medicines position peaked at $105K in Q2 2026.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.